News US imposes first rebates on drugs with price hikes Manufacturers will have to pay or face fines on drugs whose prices rose ahead of inflation.
News Novo Nordisk shadows Lilly with insulin price cut plan Danish drugmaker says it will reduce the price of its insulin products in the US by up to 75%.
Sales & Marketing Balancing interests in launching medicines Launching new medicine at the right price is a complex issue, requiring a balance of interests
News Lilly slashes insulin price 70%, patient cost cap now $35 Lilly trying to make it easier for patients to access its insulin and help Americans generally.
News CMS eyes lower prices for drugs with accelerated approval Approach could cut medicine costs and curb delays in confirmatory trials, says agency
Views & Analysis How eligible patient numbers affect price of rare disease dr... Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Life Sciences Practice team explores in greater depth the situation for thes
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
